Header links
Intranet
Donate now
image/svg+xml Map
Contact us

02/05/2024

Vall d'Hebron Talks by VHIR 'iPSC- and CRISPR-based 3D brain tissue models recapitulate key features of neurodegenerative and neurovascular diseases'
Ubicació
Sala d’actes de la planta 10 de l’Hospital General
Etiqueta
Vall d'Hebron Talks by VHIR
13/05/2024

Jornada del Dia Mundial del Lupus
Ubicació
Sala d’actes de la planta baixa de l'Hospital de Traumatologia, Rehabilitació i Cremats
Etiqueta
Jornades
22/03/2024

Defensa de Tesi 'Estudi sobre la infecció per Neisseria gonorrhoeae a Espanya: sensibilitat antibiòtica i dinàmica poblacional'
Ubicació
Aula 114 del Mòdul Sud de la Unitat Docent de Vall d'Hebron
Etiqueta
Tesis
04/04/2024

Vall d'Hebron Talks 'VIH i salut emocional'
Etiqueta
Vall d'Hebron Talks
29/04/2024

Jornada 'Dia Internacional de la Immunologia'
Ubicació
Sala d’actes de la planta 10 de l’Hospital General
Etiqueta
Jornades
22/03/2024

Taller 'Descobreix la Ciència Màgica dels Hidrogels: Una Activitat Científica i Sensorial'
Etiqueta
Taller
20/03/2024

Vall d'Hebron Talks by VHIR 'Proteomic profiling of ovarian endometriosis for recurrence risk prediction'
Ubicació
Sala d’actes de la planta baixa de l'edifici Collserola del VHIR
Etiqueta
Vall d'Hebron Talks by VHIR
10/10/2024

Curso de especialista en gestión administrativa de Ensayos Clínicos (CTA)
Etiqueta
Cursos

Seguridad, tolerancia y actividad antirretroviral de dasatinib: estudio clínico piloto enpacientes con infección reciente por el VIH-1

Contact
  • Protocol code: DASAHIVCURE
  • EudraCT code: 2021-001288-26
  • Pathology: Certes malalties infeccioses i parasitàries
  • Principal investigator:  Falcó Ferrer, Vicenç
  • Research group:  Malalties infeccioses
  • Service: Infeccioses
  • Phase: Fase IV
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de cohortes de fase 2, con un solo grupo, abierto para evaluar la seguridad, la eficacia y lafarmacocinética del tratamiento con esparsentán en pacientes pediátricos con determinadasenfermedades glomerulares proteinúricas (EPPIK).

Contact
  • Protocol code: RTRX-RE021-201
  • EudraCT code: 2021-000621-27
  • Pathology: Malalties del sistema genitourinari
  • Principal investigator:  Ariceta Iraola, Gema
  • Research group:  Fisiopatologia renal
  • Service: Nefrologia Pediàtrica
  • Phase: Fase II
  • Recruiting: Open
  • Status: Iniciat

Contact Form

I have read and accept the data protection policy *.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Subscribe to